Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial
Diabetes Care · 01.03.2026 · 49 (3) · 497-501
DOI: 10.2337/dc25-2465 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes Care, online erschienen am 26.01.2026. Verfasst von Teresa Gisinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Gonadal Steroid Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Health National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE To investigate the association of sex hormones at baseline and 1 year after a lifestyle intervention on cardiovascular (CV) risk in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS This prospective study, following the Look AHEAD: Action for Health in Diabetes (Look AHEAD) trial, of 2,260 adults with T2D, included measurements of sex hormones and sex hormone binding globulin (SHBG). Baseline levels and 1-year changes were divided into sex-specific tertiles to assess the association with CV events (n = 488 events) and weight loss interactions. RESULTS In men, higher baseline total testosterone was associated with lower CV risk (hazard ratio [HR] = 0.74; 95% CI 0.56–0.97). In men with ≥7% weight loss, SHBG increases were inversely associated with CV risk (HR = 0.47; 95% CI 0.26–0.85). In men with <7% weight loss, increases in estradiol were associated with CV risk (second vs. first estradiol tertile: HR = 1.64 [95% CI 1.13–2.38]; third vs. first estradiol tertile: HR = 1.88 [95% CI 1.29–2.73]). No associations were detected in women. CONCLUSIONS In men with T2D, but not women with T2D, sex hormones were associated with CV events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- The Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD.
- Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
- Department of Pediatrics, Division of General Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
- Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD.
- The George Institute for Global Health, School of Public Health, Imperial College London, London, U.K.
ORCID-Profile: Teresa Gisinger, Wendy L Bennett
Förderung
- Health National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gisinger, T., He, J. H., Oyeka, C. P., Ma, J., Srialluri, N., Woodward, M., Michos, E. D., Kalyani, R. R., Clark, J. M., Kautzky-Willer, A., Vaidya, D., & Bennett, W. L. (2026). Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial. Diabetes Care, 49(3), 497-501. https://doi.org/10.2337/dc25-2465
Vancouver
Gisinger T, He JH, Oyeka CP, Ma J, Srialluri N, Woodward M, et al. Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial. Diabetes Care. 2026;49(3):497-501. doi:10.2337/dc25-2465
BibTeX
@article{Gisinger2026,
author = {Gisinger, Teresa and He, Jiahuan Helen and Oyeka, Chigolum P and Ma, Jianqiao and Srialluri, Nityasree and Woodward, Mark and Michos, Erin D and Kalyani, Rita R and Clark, Jeanne M and Kautzky-Willer, Alexandra and Vaidya, Dhananjay and Bennett, Wendy L},
title = {Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {3},
pages = {497--501},
doi = {10.2337/dc25-2465}
}
EUVIMED